Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept-Reference-Cited by-同舟云学术

Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept

Published:2018-09 Issue: Volume:122 Page:42-50
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Khoshtinat Nikkhoi Shahryar,Rahbarizadeh Fatemeh^ORCID,Ahmadvand Davoud,Moghimi Seyed Moein

Funder

Tarbiat Modares University of Medical Sciences, Tehran, Iran

Iranian Council for Stem Cell Sciences and Technologies

Danish Agency for Science, Technology and Innovation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation;Aigner;Oncogene,2001

2. Single domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge;Cardoso;J. Virol.,2014

3. Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs;Chiu;Mol. Cancer Ther.,2007

4. New therapeutic approaches in breast cancer;Davies;Maturitas,2011

5. Nanobody-based products as research and diagnostic tools;De Meyer;Trends Biotechnol.,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity;International Journal of Pharmaceutics;2024-07

2. Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies;Cancer Cell International;2024-02-10

3. A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches;Journal of Drug Targeting;2023-12-28

4. Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display;Journal of Translational Medicine;2023-12-08

5. Functionalized liposomes for targeted breast cancer drug delivery;Bioactive Materials;2023-06